share_log

Hong Kong Shares End Week in Red; Sunho Biologics Gains in Debut

MT Newswires ·  May 24 16:43

Hong Kong stocks finished lower on Friday, extending losses seen in previous sessions this week, as rate cut worries continue to dampen investor sentiment.

The Hang Seng Index declined 1.38%, or 259.77 points, to close at 18,608.94. The Hang Seng China Enterprises Index fell 1.44%, or 96.54 points, to 6,605.24.

In corporate news, Sunho Biologics (HKG:2898) made a strong trading debut in Hong Kong on Friday. The clinical-stage biotech firm closed at HK$14.52 per share, up by almost 8% from its IPO price of HK$13.50.

Akeso's (HKG:9926) shares slumped nearly 23% at closing despite receiving marketing approval in China for its non-small cell lung cancer drug IVONESCIMAB.

Hong Kong-listed shares of China Vanke (HKG:2202, SHE:000002) dropped 9% after the real estate developer said it borrowed 20 billion yuan through a syndicated loan facility.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment